Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230593 · ClinicalTrials.gov registry record · NA
Chalazion Conservative Treatment Trial
A NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid, sponsored by McMaster University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT01230593: Completed NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid, sponsored by McMaster University.
NCT01230593 is a NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid that has completed, run by McMaster University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230593, a NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearing, pressure on the cornea, and irritation, all of which contribute to its morbidity. There are many anecdotal first line treatments for this condition, including warm compresses to the eyelid, topical antibiotics, topical steroids, topical combination antibiotic/steroid, and oral antibiotics. There have been no clinical trials to compare the efficacy of any of these conservative treatments. We wish to determine the most effective conservative medical treatment for chalazia.
Primary Outcome
Defined as number of patients with chalazion size regression of 100%
Conditions Studied
Interventions
- DRUG Hot Compress plus Tobramycin Drops and Ointment
- DRUG Hot compress plus Tobramycin/Dexamethasone Drops and Ointment
- OTHER Hot Compresses
Study Locations (3)
New York
- Elmhurst Hospital Center - Elmhurst
- Icahn School of Medicine at Mount Sinai - New York
Ontario
- St. Joseph's Hospital Eye Clinic - Stoney Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01230593 record still lists
NCT01230593 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 4 conditions, with Chalazion Unspecified Eye, Unspecified Eyelid appearing as the primary indexed condition, and to 3 interventions - of which Hot Compress plus Tobramycin Drops and Ointment is the first listed.
NCT01230593 reports a single indexed study location in New York, Ontario.
Frequently Asked Questions
What is clinical trial NCT01230593 about?
NCT01230593 is a clinical study titled "Chalazion Conservative Treatment Trial". An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearin...
What is the current status of trial NCT01230593?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2010-11. Estimated completion is 2016-03.
What conditions does trial NCT01230593 study?
This clinical trial studies the following conditions: Chalazion Unspecified Eye, Unspecified Eyelid, Chalazion Left Eye, Unspecified Eyelid, Chalazion Right Eye, Unspecified Eyelid, Chalazion Both Eyes.
What interventions are being tested in trial NCT01230593?
The interventions under investigation include: Hot Compress plus Tobramycin Drops and Ointment (DRUG), Hot compress plus Tobramycin/Dexamethasone Drops and Ointment (DRUG), Hot Compresses (OTHER).
Who is sponsoring clinical trial NCT01230593?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01230593 being conducted?
This trial has 3 study locations across New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01230593's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia